MedPath

ZALTRAP

ZALTRAP

Discontinued
DIN Number

02421089

Drug Class

Human

Market Date

May 8, 2014

Company
HC

sanofi-aventis canada inc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02421089
AIG Number0154950002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Schedule D ,  Prescription
A
ATC Code
L01XX44 AFLIBERCEPT
Product Specifications
Dosage FormSolution
Route of AdministrationIntravenous
AHFS Classification10:00.00
Health Canada Classification

ACTIVE INGREDIENTS (1)

AFLIBERCEPTActive
Strength: 200 MG / 8 ML
Monograph: AFLIBERCEPT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.